Baseline PET/CT characteristics
| No. of patients . | 192 . |
|---|---|
| Patients with negative PET/CT, % | 24 |
| Patients with positive PET/CT, % | 76 |
| 1-3 FLs | 32 |
| > 3 FLs | 27 |
| Diffuse | 17 |
| Patients with lower SUV (≤ 4.2), % | 54 |
| Patients with high SUV (> 4.2), % | 46 |
| Patients with EMD, % | 6 |
| 1-3 FLs, % | 25 |
| > 3FLs, % | 59 |
| Diffuse, % | 16 |
| SUV ≤ 4.2, % | 38 |
| SUV > 4.2, % | 62 |
| No. of patients . | 192 . |
|---|---|
| Patients with negative PET/CT, % | 24 |
| Patients with positive PET/CT, % | 76 |
| 1-3 FLs | 32 |
| > 3 FLs | 27 |
| Diffuse | 17 |
| Patients with lower SUV (≤ 4.2), % | 54 |
| Patients with high SUV (> 4.2), % | 46 |
| Patients with EMD, % | 6 |
| 1-3 FLs, % | 25 |
| > 3FLs, % | 59 |
| Diffuse, % | 16 |
| SUV ≤ 4.2, % | 38 |
| SUV > 4.2, % | 62 |
FL indicates focal lesion; EMD, extramedullary disease; PET/CT, positron emission tomography/computed tomography; and SUV, standardized uptake value.